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Obesity, neoadjuvant-radiotherapy, tumour proximity to the anal verge and previous abdominal 
surgery are factors that might increase the intra-operative difficulty of laparoscopic rectal cancer 
surgery. However, whether patients with these ‘high-risk’ characteristics are subject to worse short- 
or long-term outcomes is debated.  The aim of this study is to examine the short- and long-term clinical 
and oncological outcomes of patients receiving laparoscopic rectal surgery with any of these high-risk 
characteristics and compare them with patients that do not possess any of these high-risk features. 
Methods: 
For the purpose of this study data from consecutive patients receiving laparoscopic rectal cancer 
resections between 2006 and 2016 from two centres were analysed.  High-risk patients were defined 
as patients with either one of the following characteristics:  BMI ≥30, neoadjuvant-
chemoradiotherapy, tumour <8cm from the anal verge and previous abdominal surgery.   
Results: 
313 patients were identified (227 high-risk, 86 low-risk).  Short-term outcomes were similar between 
the two groups with the exception of blood loss and length of stay, which were higher in the high-risk 
group (10 vs 2.5 ml, p=0.045; 7 vs 5 days, p=0.001).   There were no statistically significant differences 
in 5-year overall survival (79.7% vs 79.8%, p=0.757), disease-free-survival (76.8% vs 69.3%, p=0.175), 
distant disease-free interval (84.8% vs 79.7%, p=0.231) and local recurrence free interval (100%, 
97.4%, p=0.162) between the two groups.   
Conclusion: 
Similar short- and long-term outcomes can be achieved in high-risk and low-risk patients receiving 
laparoscopic rectal surgery. The presented data support the suitability of laparoscopic surgery for this 
group of patients.   
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Introduction 
Laparoscopic surgery  has become the “gold standard”  for colorectal resections in the developed 
world with its benefits such as shorter hospital stay, less postoperative pain, early mobilisation and 
improved cosmesis being well established [1–6].  Two recent randomised control trials (ACOSOG 
Z6051 [7] and ALaCaRT [8]) examining the role of minimally invasive surgery (MIS) in rectal cancer 
resections have raised questions as to oncological equivalency to open surgery.  Nevertheless, 
equivalence is supported as similar local-recurrence rates and disease-free survival have been 
documented on long-term follow-up [9, 10].  However, it remains uncertain if sub-groups of patients 
considered “high-risk”, such as those with a high body mass index (BMI), those receiving neo-adjuvant 
radiotherapy or in patients with low-lying tumours are at risk of receiving sub-optimal resections when 
submitted to MIS [8]. 
Patient characteristics associated with intra-operative difficulty and categorising surgery as high-risk 
are often reported in the literature [11–24].  Several studies have demonstrated that obesity can lead 
to inferior short-term outcomes in laparoscopic colorectal surgery [11, 12, 17], although this is still 
contested in other studies [18, 19].  Neo-adjuvant radiotherapy has led to reduced locoregional 
recurrence rates and as a result its increased application in rectal cancer treatment.  However, these 
patients can represent a surgical challenge since the relative ischaemia after irradiation tends to make 
the tissues oedematous and friable, often increasing intra-operative bleeding and morbidity [20–24].  
Additionally, prior abdominal surgery and tumours close to the anal verge have been cited as risk 
factors for conversion and surgical morbidity [13–16].  Therefore, it is contested that patients with 
these characteristics are in high-risk of having worse short-term clinical and pathological outcomes 
and possibly even worse long-term oncological outcomes.  
Although the above risk factors have been investigated in the literature independently, there are only 
a few studies examining the clinical and pathological outcomes of high-risk patients in minimally 
invasive colorectal resections, with any number of the above risk factors [25–27].   This study aims to 
analyse and compare the short and long-term outcomes of high-risk and low-risk patients receiving 
laparoscopic rectal cancer surgery by a standardised modular approach to enable a baseline of 
evidence to be used as a foundation for further investigation.  
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Material and methods 
Consecutive rectal cancer patients from two centres, one from the UK and one from Portugal, who 
received laparoscopic resections between 2006 and 2016 were identified from prospectively collected 
databases.  The inclusion criteria included all patients receiving laparoscopic rectal cancer resections, 
regardless of whether they were converted to open surgery or not.  Exclusion criteria included open 
surgery and surgery for benign disease.  
Patients were stratified to high-risk or low-risk according to set criteria.  High-risk patients were 
defined as patients with either one of the following characteristics:  obese (BMI of ≥30), neoadjuvant 
radiotherapy, tumour <8cm from the anal verge and previous abdominal surgery.  Patients with none 
of the above characteristics were defined as low-risk patients.  The short-term surgical and long-term 
survival outcomes of the high-risk and low-risk patients were analysed.   
All patients with a histologically confirmed rectal adenocarcinoma were discussed in the local 
multidisciplinary team meeting (MDT) before commencing any treatment.  Rectum was defined as a 
distance of 15cm from the anal verge on MRI scan.  In general, neo-adjuvant chemoradiotherapy was 
given to patients with a threatened circumferential resection margin ≤2mm or T4 in staging on MRI, 
and not used where rectal cancers were considered resectable by total mesorectal excision (TME) with 
a likelihood of clear margins.   
Laparoscopy was the default approach for all patients with surgeries either performed or closely 
supervised by two consultant surgeons.  Contra-indications to laparoscopy were patients not deemed 
anaesthetically fit to tolerate pneumoperitoneum and patients requiring multi-visceral resections.  All 
patients with significant co-morbidities (ASA>3) underwent cardiopulmonary exercise testing by our 
anaesthetic department pre-operatively in order to assess their fitness for surgery. On this basis, three 
patients were excluded from receiving a curative resection as their primary treatment and received 
chemoradiotherapy instead. 
Two laparoscopic colorectal surgeons performed or closely supervised all procedures in each unit.  
Data collection began when the surgeons participating in this study started working in their respective 
units, in 2006 for the UK centre and 2013 for the Portuguese centre.  Surgeon A trained surgeon B in 
laparoscopic colorectal surgery and therefore both surgeons applied a modular, standardised 
previously described approach to surgery [28–30].   
Post-operative care was standardised and patients entered an enhanced recovery programme based 
on the one described by Kehlet and Wilmore [31], with the only exception being the selective use of 
epidural catheters for pain relief.  Patients were discharged home when assessed as meeting set 
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criteria for discharge.  Patients were followed up 6 weeks following their surgery and had subsequent 
6-monthly follow up appointments for the first 2 years and further annual clinic appointments up to 5 
years.  The colon was examined at the 2nd and 5th year following surgery.  CT scans of the chest, 
abdomen and pelvis were performed on an annual basis for first 3 years and at 5 years. 
All recruited patients signed an informed consent form allowing their data to be used for analysis and 
its publishing.  The requirements for anonymization of personal dataset by the Data Protection Act 
1998 were satisfied.  According to the Health Research Authority (HRA), this study was not classified 
to need their approval as it is an audit. 
Surgical technique 
All procedures were performed through a well-established, previously described, standardised 
modular technique  [28, 32].  This approach permits a safe and reproducible technique that also 
facilitates teaching and training [29].   
The patients were placed in the modified Lloyd Davies position.  The optical port was placed infra-
umbilical in the midline with the open Hassan technique and pneumoperitoneum was established. 
Pressure was set to 12mmHg.  Further ports were inserted under direct vision at the right iliac fossa, 
right upper quadrant and left upper quadrant as demonstrated in a previously published video article 
[33].   Procedures commenced with medial to lateral dissection followed by vascular control by ligating 
the main vessels.  Hem-o-lok’s® were used to secure the vessels before division and a  three step 
approach was used for splenic mobilisation [34].  These included: 1) medial to lateral dissection 
towards and above the pancreas, 2) lateral colonic mobilisation and 3) separation of omentum from 
transverse colon.  TME started with posterior mobilization followed by right lateral, anterior and left 
lateral mobilisation in a stepwise manner.  Dissection was performed by monopolar diathermy.  All 
patients receiving complete TME surgery were given pre-operative bowel preparation the day before 
surgery and had loop ileostomies fashioned in cases where an anastomosis was formed. 
Data collection and outcome assessment 
All data was retrospectively collected from prospectively collated databases.  Baseline characteristics 
analysed were age, gender, body mass index (BMI), American Society of Anaesthesiologists (ASA) 
grade, operating surgeon, previous abdominal surgery (defined as any patients with previous open 
abdominal surgery which involved bowel manipulation or resection, these operations included any 
open bowel resection, appendicectomy and hysterectomy), tumour distance from the anal verge, 
neoadjuvant radiotherapy, operation performed tumour (T) stage (pathological T stage was used) and 
American Joint Committee on Cancer (AJCC) stage.  Short-term outcomes examined included 
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operative time, estimated blood loss (EBL), conversion to open (defined as any incision needed to 
either mobilise the colon or rectum or ligate the vessels), length of stay (LOS), 30-day readmission, 30-
day reoperation, 30-day mortality, clinical anastomotic leak, lymph node yield and circumferential 
resection margin (CRM) clearance.  Long-term outcomes investigated included 5-year overall survival 
(OS), disease free survival (DFS), distant disease-free interval and local recurrence free interval.  
Distant-disease and local recurrence free intervals specifically investigate the time to distant or local 
disease recurrence respectively and do not account for deaths [35].  Distant recurrence was defined 
as any evidence on imaging of metastatic disease in a new site. Local recurrence was defined as any 
evidence on imaging or endoscopy of disease in the pelvis or anastomotic site.  Any of these findings 
led to an MDT discussion to confirm this.  Survival and disease recurrence status were checked on a 
regular basis from all electronic records by a designated data manager and updated on the databases. 
Statistical analysis 
Data analysis was performed using IBM SPSS version 24 (SPSS Inc., Chicago, IL, USA).  Non-parametric 
data was expressed as median with interquartile range and parametric data as mean with standard 
deviation.  Cohort demographic and clinical characteristics were compared using χ2 test or Fishers 
exact test for categorical variables, Mann-Whitney U test for non-parametric continuous variables and 
t test for parametric continuous variables.  P values of <0.05 were considered statistically significant.   
A univariate and multivariate binary logistic regression model was applied to investigate whether 
being a high-risk patient affected morbidity and mortality.  Morbidity and mortality were defined as 
the presence of any of the following outcomes: 30-day reoperation, 30-day readmission, anastomotic 
leak and 30-day mortality.  Characteristics investigated included: age, gender, ASA grade, BMI, 
presence of previous abdominal surgery, tumour distance from the anal verge, T stage and 
neoadjuvant radiotherapy.  When assessing whether high-risk patients influenced morbidity and 
mortality, BMI, abdominal surgery, tumour distance from the anal verge and neoadjuvant 
radiotherapy where not included in the analysis since these were the factors defining patients as high-
risk in the study.  The constant was included in the analysis model and data is presented as odds ratio 
(OR), 95% confidence interval (95% CI) and p value.    
All long-term outcomes were calculated by applying Kaplan-Meier analysis [36].  OS, DFS, distant 
disease-free interval and local recurrence free interval definitions were based the STEEP system 
published in 2007 [35].  Events included in order to calculate each long-term outcome were: 
• OS: all deaths 
• DFS: all deaths and disease recurrences (whether local or distal) 
• distant disease-free interval: all distant recurrences 
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• local recurrence free interval: all local recurrences 
Statistical significance was determined by the log rank test, Breslow test or Tarone-Ware test as 
appropriate [37].  Maximum follow up was set to five years and median follow up time was determined 
by the Schemper and Smith method [38]. In this method a Kaplan-Meier analysis is performed with 
the event indicator reversed so that the outcome of interest is censored. This method is more robust 
than simply calculating the median time of follow up of all patients [39].  Univariate and multivariate 
Cox-regression models were applied to identify risk factors affecting OS.  Outcomes assessed included: 
age, gender, ASA grade, BMI, presence of previous abdominal surgery, tumour distance from the anal 
verge, neoadjuvant radiotherapy and AJCC stage.  Data is presented as hazard ratio (HR), 95% 
confidence interval and p value. 
A subgroup analysis of the high-risk cohort was performed in order to investigate whether the number 
of risk factors (obesity, neoadjuvant radiotherapy, tumour <8cm from the anal verge and previous 
abdominal surgery) affected morbidity & mortality and overall survival.  Logistic regression and cox-
regression models were applied as above for this purpose.  
 
Results 
A total of 313 patients received laparoscopic rectal cancer resections, with 270 patients from the UK 
centre and 43 from the Portuguese centre.  There was a total of 227 (72.5%) patients in the high-risk 
group and 86 (27.5%) in the low-risk group.   
Cohort characteristics 
The two cohorts were similar in terms of age, gender, operating surgeon, ASA grade and AJCC stage.  
In the high-risk group 35.6% of the patients were obese, 36.6% had previous abdominal surgery, 56.8% 
had low lying tumours and 33% received neo-adjuvant radiotherapy.  Furthermore, as expected there 
were differences in the procedures performed, with more abdominoperineal resections (APER) in the 
high-risk group.  Table 1 summarises the above findings.   
Short-term outcomes 
The short-term surgical outcomes of the two groups are summarised in table 2. Median EBL and length 
of stay were longer in the high-risk group (low-risk vs high-risk: EBL 2.5 vs 10 ml; LOS 5 vs 7 days).  
There were no other statistically significant differences in any of the remaining investigated outcomes 
between the two cohorts.  Conversion rate was 1.2% and 2.2% in the low and high-risk groups 
respectively (p=1.000).  There were only two 30-day mortalities reported, both in the high-risk group 
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(0.9%), the two patients were 75 and 77 years old respectively, both received APER’s and both died 
from myocardial infractions. Clinical anastomotic leak rate was 2.4% and 3.4% in the low and high-risk 
groups respectively.    
Logistic regression analysis for morbidity and mortality 
Univariate and multivariate regression analysis showed that high-risk patients and male gender were 
associated with a greater risk of morbidity and mortality (defined as the presence of any of the 
following outcomes: 30-day reoperation, 30-day readmission, anastomotic leak and 30-day mortality).  
Table 3 summarises the regression analysis for morbidity and mortality.  
Five-year long-term outcomes 
There was a total of 54 deaths (15 low-risk, 39 high-risk group) and 54 recurrences (11 low-risk, 43 
high-risk group) in the examined study population.  Regarding disease recurrence, there were 51 
patients that suffered from distant (11 low risk, 40 high-risk group) and 5 from local recurrence (0 low 
risk, 5 high-risk group).  Two patients had both distant and local recurrence.  
There were no differences in 5-year OS (79.7% vs 79.8%, p=0.757), DFS (76.8% vs 69.3%, p=0.175), 
distant disease-free interval (84.8% vs 79.7%, p=0.231) and local recurrence free interval (100%, 
97.4%, p=0.162) between the low-risk and high-risk groups.  Median follow up was 5 years for OS and 
DFS, 4.55 years for distant disease-free interval and 4.21 years for local recurrence free interval.  Table 
4 and figures 1-4 illustrate these results. 
Stage by stage analysis of DFS demonstrated there were no differences between the two groups at 
any stage (see table 5).   
Cox-regression analysis 
In univariate cox-regression analysis for OS, age, ASA grade, neo-adjuvant radiotherapy and AJCC stage 
were found to affect OS, with all factors linked with a worse OS outcome.  However, in multivariate 
cox-regression analysis age, AJCC stage and neo-adjuvant radiotherapy, but not ASA grade, were 
found to affect OS.  Table 6 summarises the cox-regression model analysis results for OS. 
Number of risk factors 
In the high-risk cohort, 52% (n=117) of the patients had one of the risk factors defining them as high 
risk, 36.1% of the patients had two risk factors, 10.1% had three risk factors and 1.8% had all four 
risk factors. From the patients that only had one risk factor, 33 (28%) were obese, 31 (26%) had 
previous abdominal surgery, 36 (31%) had tumours <8cm from the anal verge and 17 (15%) received 
neo-adjuvant treatment. In a subgroup analysis of the high-risk cohort, the number of risk factors 
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patients carried did not affect morbidity and mortality in logistic regression analysis (Univariate: OR 
1.019, 95% CI 0.663-1.567, p=0.930; multivariate: OR 1.058, 95% CI 0.673-1.662, p=0.808) and did 
not affect overall survival in cox-regression analysis (univariate: HR 1.476, 95% CI 0.997-2.186, 
p=0.052; multivariate: HR 1.470, 95% CI 0.971-2.225, p=0.069). 
 
Discussion 
Recent results from large international randomised control trials have questioned the oncological 
safety of laparoscopic rectal cancer surgery [7, 8], with these concerns being highlighted in patients 
with certain characteristics classifying them as high-risk.  In this study we compare the short-and long-
term clinical and oncological outcomes of high-risk and low-risk patients undergoing rectal MIS.  We 
observed overall good short and long-term outcomes for both groups of patients and although the 
high-risk group might be associated with a higher morbidity profile, long term oncological outcomes 
were similar between the two groups.  Our results support the hypothesis that, when standardised 
modular surgery and peri-operative care is applied, laparoscopic rectal cancer surgery can be safely 
used and offers good short and long-term results, in both low-risk and high-risk patients. 
Patient characteristics influencing the surgical outcomes of colorectal resections have been 
extensively reported in the literature [11–24].  However, these tend to be investigated independently, 
such as the influence of obesity or neo-adjuvant radiotherapy on colorectal surgery [11, 12, 17–24].  
There are only a few studies investigating the outcomes of high-risk patients submitted to colorectal 
resections [25–27].  These studies have reported good short-term outcomes for MIS in high-risk 
colorectal patients confirming its safety and feasibility, although the criteria used to define a case as 
high-risk differ between these studies [25–27].  Furthermore, two of these studies include a significant 
number of colonic resections (Marks et al. [25] 75%, Hemandas et al. [26] 68%).   
Our study focused on rectal cancer and arguably represents the largest series of high-risk laparoscopic 
rectal resections.  In addition, it presents long-term data and oncological outcomes.  Interestingly, by 
just applying the four criteria used in our study, the majority of our patients (72.5%) were classified as 
high-risk.   It is important to note that there are no generally accepted definitions for high risk factors 
and the above studies have all used slightly different risk factor criteria.   
With the exception of LOS and EBL there were no differences in the short-term clinical and 
pathological outcomes between the low-risk and high-risk groups.  The difference in EBL (2.5 vs 10 ml) 
is small and is unlikely to be clinically significant.  In addition, considering blood loss is very difficult to 
accurately quantify the reported difference could be attributed to the way EBL was measured. The 
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longer LOS in the high-risk group could be explained by the increased number of stomas in this group 
– 19% vs 1% APER’s – and significantly more patients with low-lying tumours, all of which would have 
had defunctioning ileostomies.  An alternative explanation to the increased length of stay observed in 
the high-risk group might be due to an increased morbidity profile.  In further univariate regression 
analysis (not shown), male gender, increasing BMI and low-lying tumours conveyed a higher morbidity 
and mortality, with male gender and low-lying tumours continuing to be statistically significant in 
multivariate analysis.  Therefore, it may be possible that the technical challenges encountered in the 
narrow male pelvis and that of tumours close to the anal verge have a negative impact on the short-
term clinical outcomes.  Furthermore, ASA grade has a trend towards negatively impacting morbidity 
and mortality, although this did not reach statistical significance (table 3). 
Of note, our reported observed pathological outcomes (surrogate features of safe oncological 
resection and good specimen quality) in the high-risk group support the safety and feasibility of 
laparoscopic surgery in this group of patients.  Additionally, when comparing our results with those of 
the ACOSOG [7] and ALaCaRT [8] trials, conversion rate (ACOSOG: 11.3%, ALaCaRT: 9%) and R0 
resection rate (ACOSOG: 87.7%, ALaCaRT: 93%) were superior in our study (1.9%, 96% respectively), 
while mortality was similar.   
We propose the potential reason for these different outcomes is that surgeries in the ACOSOG and 
ALaCaRT trials were performed by a wide range of surgeons and hospitals with mixed experience and 
volume, whereas in our study all procedures were performed in high volume centres by experienced 
laparoscopic surgeons, within a dedicated multidisciplinary environment.  In addition, both surgeons 
in our study applied a reproducible, standardised approach to TME [28], while in the ACOSOG and 
ALaCaRT trials there was great variability in the way surgeries were conducted.  We believe that by 
standardising operative technique and breaking down complex surgical procedures in limited extent 
modules, we enhance reproducibility of results and facilitate surgical training and research.  This way, 
surgical outcomes may become fairly predictable, regardless of the surgeon or peri-operative 
conditions.  The importance of standardising operative technique in training and producing 
reproducible outcomes is demonstrated in two recent publications [40, 41]. 
The reported long-term outcomes of our study confirm the oncological safety of laparoscopic surgery 
in high-risk rectal cancer patients.  OS, DFS, distant disease-free interval and local recurrence free 
interval were similar between both risk groups in our study (table 4, figures 1-4).  In addition, DFS was 
similar in a stage by stage analysis (table 5).  Our observed OS and DFS in the high-risk group is 
comparable to that of the COREAN [6] and CLASICC [1] trials, two major trials demonstrating similar 
long-term oncological outcomes between laparoscopic and open rectal cancer surgery.  Furthermore, 
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our study replicates the recently published long term results of ACOSOG Z6051 (79.5% DFS at 2 years) 
and ALaCaRT (80% DFS and 94% OS at 2 years) trials [9, 10].   
We acknowledge there are differences in terms of demographics and study characteristics between 
the discussed studies.  Nevertheless, our results support the oncological safety of MIS for high-risk 
rectal cancers, and are at least equivalent to those of major recent trials.  In cox-regression analysis 
age, neo-adjuvant radiotherapy and AJCC stage where found to affect OS.  The fact that AJCC stage 
and age could affect OS is self-evident.  However, the effect of neo-adjuvant radiotherapy on OS is 
likely to be secondary to confounding factors that have not been accounted for, since neo-adjuvant 
radiotherapy was only reserved for tumours that breached or threatened the CRM in our study. 
The strengths of this study lie on its large sample size, the method that data was collected 
consecutively from two centres from two different countries, with dedicated multidisciplinary 
oncological teams, and its novelty in examining the long-term oncological outcomes of high-risk 
patients.  In addition, data is contemporary, rather than data collected as part of a study that possibly 
includes an element of performance bias in surgical trials [42, 43].  Acknowledging its limitations, our 
study is retrospective in nature despite collecting data from prospectively maintained databases.  
Furthermore, although morbidity is assessed in this study by analysing readmission, reoperation and 
anastomotic leak rates; minor post-operative complications were not recorded (Clavien-Dindo 1-2).  
This is because minor complication data is harder to accurately record and can be easily missed.  
Although we acknowledge this might introduce observational bias, we know as demonstrated from 
previous studies published by the Cleveland group [44, 45] that readmission rate, length of stay and 
mortality can predict surgical morbidity, without the need to collect data for all complications.   
Conclusion 
In summary, our study has demonstrated that when operative technique and peri-operative care are 
standardised, laparoscopic rectal cancer surgery in high-risk patients is safe and offers similar short- 
and long-term outcomes to those of low-risk patients.  Although high-risk patients might be associated 
with a higher morbidity profile, the observed short-term outcomes in our study confirm the suitability 
of laparoscopic surgery for this group of patients.  We believe that in the hands of experienced 
surgeons, high-risk rectal cancer surgery patients should be considered for laparoscopic surgery.  For 
these results to be validated larger scale multi-centre observational studies or trials are required.  
These should investigate the outcomes of high-risk rectal cancer patients receiving laparoscopic rectal 
cancer surgery by a standardised operative technique and peri-operative care pathway. 
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Table 1. Baseline characteristics of low-risk vs high-risk patients 
 
 Low risk (n=86) High risk (n=227) P value 












Median BMI 25.9 (24-27) 27.2 (24-31) .000m 




















0 83 (36.6%) .000f 
Median distance from 
anal verge in cm 
10 (10-14) 7 (5-10) .000m 
Low tumour (<8cm) * 0 129 (56.8%) .000f 
Neoadjuvant 
radiotherapy* 






































*criteria for high risk 
 
APER: Abdominoperineal excision; m: Mann-Whitney U; c: Chi square; f: Fisher’s exact  
 
  
18 | P a g e  
 
Table 2. Short term clinical and pathological outcomes of low-risk vs high-risk patients 
 Low-risk High-risk P value 
Median operation time 
in min 
215 (186.3-250) 220 (205-255) 0.091m 
Median estimated blood 
loss in ml 
2.5 (0-20) 10 (0-40) 0.045m* 
Conversion 1 (1.2%) 5 (2.2%) 1.000f 
Median LOS in days 5 (4-8) 7 (5-11) 0.001m* 
30-day mortality 0 2 (0.9%) 1.000f 
30-day readmission 9 (10.5%) 37 (16.3%) 0.193c 
30-day reoperation 2 (2.3%) 9 (4%) 0.733f 
Anastomotic leak 2 (2.4%) 6 (3.4%) 1.000f 
CRM (R0) 83 (96.5%) 218 (96%) 0.673c 
Lymph node yield 13 (8-19.5) 15 (10-21) 0.317m 
 
LOS: length of stay; CRM: circumferential resection margin; m: Mann-Whitney U; f: Fisher’s exact; c: 
Chi square; * statistically significant 
 
 
Table 3. Univariate and multivariate logistic regression investigating the effect of high-risk on 
morbidity and mortality 
 Univariate Multivariate 
 OR 95% CI p value OR 95% CI p value 
High risk 2.294 1.073 - 4.908 0.032* 2.321 1.072 - 5.023 0.033* 
age 0.994 0.969-1.019 0.630 0.986 0.958 – 1.015 0.341 
Male gender 2.136 1.112-4.101 0.023* 2.121 1.082 – 4.161 0.029* 
ASA grade 1.653 0.998-2.739 0.051 1.745 0.992 – 3.071 0.053 
T stage 1.036 0.744-1.442 0.835 0.997 0.697 – 1.427 0.987 
 
OR: odds ratio; CI: confidence interval; * statistically significant 
 
Table 4. Five-year long-term outcomes of laparoscopic rectal cancer resections 
 Low-risk High-risk p value Median follow up 
OS 79.7% 79.8% 0.757 5 years 
DFS 76.8% 69.3% 0.175 5 years 
Distant disease- 
free interval 
84.8% 79.7% 0.231 4.55 years 
Local recurrence 
free interval 
100% 97.4% 0.162 4.21 years 
 
OS: overall survival; DFS: disease-free survival 
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Table 6. Univariate and multivariate Cox-regression analysis for overall survival 
 







AJCC stage Low-risk High-risk p value Median follow up 
1 90.9% 82.4% 0.311 4.81 years 
2 81.1% 67% 0.254 5.00 years 
3 64.6% 64.9% 0.764 5.00 years 
 Univariate Multivariate 
 HR 95% CI p value HR 95% CI p value 
age 1.064 1.036 - 1.092 .000* 1.061 1.029 - 1.094 .000* 
Male gender .958 .554 - 1.656 .878 .902 .510 - 1.593 .722 
BMI .944 .885 - 1.008 .084 .987 .921 - 1.058 .717 




.973 .903 - 1.875 .949 .954 .505 - 1.801 .884 
Anal verge 
distance 




.398 .230 - .688 .001* .443 .232 - .848 .014* 
AJCC stage 1.912 1.439 - 2.541 .000* 1.864 1.370 - 2.535 .000* 




Fig. 1. Overall survival for high-risk vs low-risk laparoscopic rectal resections 
Fig. 2. Disease free survival for high-risk vs low-risk laparoscopic rectal resections 
Fig. 3. Distant disease-free survival for high-risk vs low-risk laparoscopic rectal resections 
Fig. 4. Local recurrence free interval for high-risk vs low-risk laparoscopic rectal resections 
















23 | P a g e  
 
 
 
Figure 4 
 
 
 
Figure 5 
